DK136976C - - Google Patents

Info

Publication number
DK136976C
DK136976C DK169573A DK169573A DK136976C DK 136976 C DK136976 C DK 136976C DK 169573 A DK169573 A DK 169573A DK 169573 A DK169573 A DK 169573A DK 136976 C DK136976 C DK 136976C
Authority
DK
Denmark
Application number
DK169573A
Other languages
Danish (da)
Other versions
DK136976B (da
Inventor
W A Bolhofer
Original Assignee
Merck & Co Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc. filed Critical Merck & Co Inc.
Publication of DK136976B publication Critical patent/DK136976B/da
Application granted granted Critical
Publication of DK136976C publication Critical patent/DK136976C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK169573AA 1972-04-11 1973-03-28 Analogifremgangsmåde til fremstilling af 2-(alfa-(3-trifluormethylphenoxy)-4-chlorbenzyl)-2-oxazolin eller syreadditionssalte deraf. DK136976B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00243480A US3816446A (en) 1972-04-11 1972-04-11 (alpha-(3-trifluoromethylphenoxy)-4-chlorobenzyl)heterocycles

Publications (2)

Publication Number Publication Date
DK136976B DK136976B (da) 1977-12-27
DK136976C true DK136976C (cg-RX-API-DMAC7.html) 1978-06-05

Family

ID=22918919

Family Applications (1)

Application Number Title Priority Date Filing Date
DK169573AA DK136976B (da) 1972-04-11 1973-03-28 Analogifremgangsmåde til fremstilling af 2-(alfa-(3-trifluormethylphenoxy)-4-chlorbenzyl)-2-oxazolin eller syreadditionssalte deraf.

Country Status (9)

Country Link
US (1) US3816446A (cg-RX-API-DMAC7.html)
JP (1) JPS5030620B2 (cg-RX-API-DMAC7.html)
CH (1) CH589636A5 (cg-RX-API-DMAC7.html)
DE (1) DE2318002A1 (cg-RX-API-DMAC7.html)
DK (1) DK136976B (cg-RX-API-DMAC7.html)
FR (1) FR2182952B1 (cg-RX-API-DMAC7.html)
GB (1) GB1388790A (cg-RX-API-DMAC7.html)
NL (1) NL7304333A (cg-RX-API-DMAC7.html)
SE (1) SE380524B (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953465A (en) * 1972-04-11 1976-04-27 Merck & Co., Inc. 2-[α-(3-Trifluoromethylphenoxyl)-4-chlorobenzyl]oxazole and methods for preparing the same
US3953490A (en) * 1972-07-13 1976-04-27 Merck & Co., Inc. Preparation of (3-trifluoromethylphenoxy)(4-chlorophenyl)acetonitrile
JPS50116306U (cg-RX-API-DMAC7.html) * 1974-03-05 1975-09-22
JPS50137193U (cg-RX-API-DMAC7.html) * 1974-04-25 1975-11-12
JPS5111502A (en) * 1974-07-19 1976-01-29 Matsushita Electric Industrial Co Ltd Senkyokusochi
JPS544877Y2 (cg-RX-API-DMAC7.html) * 1976-12-03 1979-03-01
DE3161525D1 (en) * 1980-03-05 1984-01-05 Ciba Geigy Ag Herbicidally active 2-nitro-5-phenoxyphenyl oxazoles, oxazines, imidazoles, pyrimidines and thiazoles, their preparation and their use
US4870187A (en) * 1988-08-23 1989-09-26 Bristol-Myers Company Antihypercholesterolemic tetrazol-1-yl compounds
FR2766821A1 (fr) * 1997-07-29 1999-02-05 Sanofi Sa Derives de 1,3-oxazolinyl-biphenyle, leur procede de preparation et leur utilisation comme intermediaires de synthese
JP2004521124A (ja) * 2001-02-09 2004-07-15 メルク エンド カムパニー インコーポレーテッド 糖尿病および脂質障害用の2−アリールオキシ−2−アリールアルカン酸類
CN1922143A (zh) * 2004-02-18 2007-02-28 麦它波莱克斯股份有限公司 作为抗糖尿病药的α-(三氟甲基-取代的芳氧基、芳基氨基、芳硫基或芳基甲基)-三氟甲基-取代的苯乙酸和衍生物
BRPI0511510A (pt) 2004-05-25 2007-12-26 Metabolex Inc composto, sais, solvatos, hidratos e pró-drogas farmaceuticamente aceitáveis do mesmo, composição, e, métodos para modular um receptor ativado com proliferador de peroxisoma, para tratar doença, para modular resistência à insulina, para tratar um ou mais fatores de risco para doença cardiovascular, para diminuir nìveis de fibrinogênio, para diminiuir ldlc, para suprimir apetite, e para modular nìveis de leptina em um indivìduo

Also Published As

Publication number Publication date
FR2182952B1 (cg-RX-API-DMAC7.html) 1975-10-31
NL7304333A (cg-RX-API-DMAC7.html) 1973-10-15
JPS497275A (cg-RX-API-DMAC7.html) 1974-01-22
GB1388790A (en) 1975-03-26
JPS5030620B2 (cg-RX-API-DMAC7.html) 1975-10-02
FR2182952A1 (cg-RX-API-DMAC7.html) 1973-12-14
US3816446A (en) 1974-06-11
SE380524B (sv) 1975-11-10
DK136976B (da) 1977-12-27
DE2318002A1 (de) 1973-10-31
CH589636A5 (cg-RX-API-DMAC7.html) 1977-07-15

Similar Documents

Publication Publication Date Title
DK136976C (cg-RX-API-DMAC7.html)
JPS4985908A (cg-RX-API-DMAC7.html)
JPS5336228B2 (cg-RX-API-DMAC7.html)
FR2180574B2 (cg-RX-API-DMAC7.html)
JPS4921672A (cg-RX-API-DMAC7.html)
JPS4944692A (cg-RX-API-DMAC7.html)
JPS4889639U (cg-RX-API-DMAC7.html)
JPS4985278A (cg-RX-API-DMAC7.html)
JPS4899690A (cg-RX-API-DMAC7.html)
JPS4890864A (cg-RX-API-DMAC7.html)
JPS4884660A (cg-RX-API-DMAC7.html)
JPS4922247U (cg-RX-API-DMAC7.html)
BG18742A1 (cg-RX-API-DMAC7.html)
CH564523A5 (cg-RX-API-DMAC7.html)
SE7103790L (cg-RX-API-DMAC7.html)
BG18270A1 (cg-RX-API-DMAC7.html)
BG19408A1 (cg-RX-API-DMAC7.html)
BG18961A1 (cg-RX-API-DMAC7.html)
BG18906A1 (cg-RX-API-DMAC7.html)
BG18222A1 (cg-RX-API-DMAC7.html)
BG18728A1 (cg-RX-API-DMAC7.html)
BG18717A1 (cg-RX-API-DMAC7.html)
CH559034A5 (cg-RX-API-DMAC7.html)
CH564259A5 (cg-RX-API-DMAC7.html)
DD104521A5 (cg-RX-API-DMAC7.html)